Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
Conditions: Type 2 Diabetes; Heart Failure, Reduced Ejection Fraction Interventions: Drug: Ketone Monoester (KE) Sponsors: The University of Texas Health Science Center at San Antonio; National Center for Advancing Translational Sciences (NCATS) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Research | Science | Texas University